                               SEQUENCE LISTING

<110> ELASTOGENESIS, LLC
      THE HOSPITAL FOR SICK CHILDREN
 
<120> DERMAL COMPOSITIONS AND METHODS OF USE

<130> 147476.02402

<140>
<141>

<150> 62/697,741
<151> 2018-07-13

<150> 62/694,560
<151> 2018-07-06

<150> 62/694,533
<151> 2018-07-06

<150> 62/694,522
<151> 2018-07-06

<150> 62/694,514
<151> 2018-07-06

<160> 79    

<170> PatentIn version 3.5

<210> 1
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 1
Gly Ala Ala Pro Gly 
1               5   


<210> 2
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 2
Gly Val Val Pro Gly 
1               5   


<210> 3
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 3
Gly Gly Gly Pro Gly 
1               5   


<210> 4
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 4
Gly Leu Leu Pro Gly 
1               5   


<210> 5
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 5
Gly Ile Ile Pro Gly 
1               5   


<210> 6
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 6
Gly Ser Ser Pro Gly 
1               5   


<210> 7
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 7
Gly Thr Thr Pro Gly 
1               5   


<210> 8
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 8
Gly Cys Cys Pro Gly 
1               5   


<210> 9
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 9
Gly Met Met Pro Gly 
1               5   


<210> 10
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 10
Gly Phe Phe Pro Gly 
1               5   


<210> 11
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 11
Gly Tyr Tyr Pro Gly 
1               5   


<210> 12
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 12
Gly Trp Trp Pro Gly 
1               5   


<210> 13
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 13
Gly Asp Asp Pro Gly 
1               5   


<210> 14
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 14
Gly Asn Asn Pro Gly 
1               5   


<210> 15
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 15
Gly Glu Glu Pro Gly 
1               5   


<210> 16
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 16
Gly Gln Gln Pro Gly 
1               5   


<210> 17
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 17
Gly Arg Arg Pro Gly 
1               5   


<210> 18
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 18
Gly His His Pro Gly 
1               5   


<210> 19
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 19
Gly Lys Lys Pro Gly 
1               5   


<210> 20
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 20
Gly Pro Pro Pro Gly 
1               5   


<210> 21
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (2)..(3)
<223> 3-hydroxyproline 

<400> 21
Gly Pro Pro Pro Gly 
1               5   


<210> 22
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (2)..(3)
<223> 4-hydroxyproline 

<400> 22
Gly Pro Pro Pro Gly 
1               5   


<210> 23
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 23
Arg Arg Pro Glu Val 
1               5   


<210> 24
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 24
Gln Pro Ser Gln Pro Gly Gly Val 
1               5               


<210> 25
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 25
Pro Gly Gly Val 
1               


<210> 26
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 26
Gly Pro Gly Val 
1               


<210> 27
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 27
Lys Pro Gly Val 
1               


<210> 28
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 28
Gly Pro Gly Leu 
1               


<210> 29
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 29
Glu Gly Ser Ala 
1               


<210> 30
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 30
Pro Gly Gly Phe 
1               


<210> 31
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 31
Gly Gly Gly Ala 
1               


<210> 32
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 32
Lys Pro Gly Lys Val 
1               5   


<210> 33
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 33
Pro Gly Gly Val 
1               


<210> 34
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 34
Lys Pro Lys Ala 
1               


<210> 35
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 35
Gly Pro Gly Gly Val 
1               5   


<210> 36
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 36
Gly Pro Gln Ala 
1               


<210> 37
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 37
Gly Gly Pro Gly Ile 
1               5   


<210> 38
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 38
Pro Gly Pro Gly Ala 
1               5   


<210> 39
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 39
Gly Pro Gly Gly Val 
1               5   


<210> 40
<211> 4
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 40
Gly Gln Pro Phe 
1               


<210> 41
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 41
Gly Gly Lys Pro Pro Lys Pro Phe 
1               5               


<210> 42
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 42
Gly Gly Gln Gln Pro Gly Leu 
1               5           


<210> 43
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 43
Gly Gly Pro Gly Ile 
1               5   


<210> 44
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 44
Val Gly Val Ala Pro Gly 
1               5       


<210> 45
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 45
Ile Gly Val Ala Pro Gly 
1               5       


<210> 46
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 46
Pro Gly Gly Val Leu Pro Gly 
1               5           


<210> 47
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 47
Val Gly Val Val Pro Gly 
1               5       


<210> 48
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 48
Ile Gly Leu Gly Pro Gly Gly Val 
1               5               


<210> 49
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 49
Val Gly Ala Met Pro Gly 
1               5       


<210> 50
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 50
Val Gly Leu Ser Pro Gly 
1               5       


<210> 51
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 51
Ile Gly Ala Met Pro Gly 
1               5       


<210> 52
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 52
Ile Gly Leu Ser Pro Gly 
1               5       


<210> 53
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 53
Gly Val Ala Pro Gly Val 
1               5       


<210> 54
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 54
Val Ala Pro Gly Val Gly 
1               5       


<210> 55
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 55
Ala Pro Gly Val Gly Val 
1               5       


<210> 56
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 56
Pro Gly Val Gly Val Ala 
1               5       


<210> 57
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 57
Gly Val Gly Val Ala Pro 
1               5       


<210> 58
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 58
Val Gly Leu Met Pro Gly 
1               5       


<210> 59
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 59
Val Gly Val Met Pro Gly 
1               5       


<210> 60
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 60
Val Gly Ala Ser Pro Gly 
1               5       


<210> 61
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 61
Val Gly Ala Ala Pro Gly 
1               5       


<210> 62
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 62
Ile Gly Leu Met Pro Gly 
1               5       


<210> 63
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 63
Ile Gly Val Met Pro Gly 
1               5       


<210> 64
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 64
Ile Gly Ala Ser Pro Gly 
1               5       


<210> 65
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 65
Ile Gly Ala Ala Pro Gly 
1               5       


<210> 66
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 66
Ile Gly Leu Ser Pro Gly 
1               5       


<210> 67
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 67
Ile Gly Leu Ala Pro Gly 
1               5       


<210> 68
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 68
Ile Gly Val Ser Pro Gly 
1               5       


<210> 69
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 69
Val Gly Leu Ala Pro Gly 
1               5       


<210> 70
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 70
Val Gly Val Ser Pro Gly 
1               5       


<210> 71
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<220>
<223> N-terminal acetylation

<400> 71
Ile Gly Val Ala Pro Gly 
1               5       


<210> 72
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Val or Ile

<220>
<221> MOD_RES
<222> (2)..(2)
<223> Gly or Val

<220>
<221> MOD_RES
<222> (3)..(3)
<223> Ala, Val, or Leu

<220>
<221> MOD_RES
<222> (4)..(4)
<223> Met, Ser, Ala, or Thr

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Ala or Pro

<400> 72
Xaa Xaa Xaa Xaa Xaa Gly 
1               5       


<210> 73
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Val or Ile 

<220>
<221> MOD_RES
<222> (3)..(3)
<223> Ala or Leu

<220>
<221> MOD_RES
<222> (4)..(4)
<223> Met or Ser 

<400> 73
Xaa Gly Xaa Xaa Pro Gly 
1               5       


<210> 74
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 74
Val Gly Ala Met Pro Gly Ala Ala Ala Ala Ala Val Gly Ala Met Pro 
1               5                   10                  15      


Gly 
    


<210> 75
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 75
Val Gly Leu Ser Pro Gly Ala Ala Ala Ala Ala Val Gly Leu Ser Pro 
1               5                   10                  15      


Gly 
    


<210> 76
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 76
Val Gly Val Ala Pro Gly Ala Ala Ala Ala Ala Val Gly Val Ala Pro 
1               5                   10                  15      


Gly 
    


<210> 77
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 77
Ile Gly Ala Met Pro Gly Ala Ala Ala Ala Ala Ile Gly Ala Met Pro 
1               5                   10                  15      


Gly 
    


<210> 78
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 78
Ile Gly Leu Ser Pro Gly Ala Ala Ala Ala Ala Ile Gly Leu Ser Pro 
1               5                   10                  15      


Gly 
    


<210> 79
<211> 17
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 79
Ile Gly Val Ala Pro Gly Ala Ala Ala Ala Ala Ile Gly Val Ala Pro 
1               5                   10                  15      


Gly 
    




